We describe a protocol for generating cornea organoids from iPSCs derived from aniridia patients, creating a patient-specific model to study corneal disorders. These organoids mimic key structural and functional features, providing a reliable in vitro platform for investigating disease mechanisms, testing potential treatments, and advancing personalized regenerative approaches for anterior eye diseases.
